A Partner in Health
A new chapter, a new approach. Collaborating with physicians and other healthcare professionals, focusing on R&D and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Work with Us
Join Covidien, where we appreciate your talent, your experience and your passion for your work. Our culture thrives because we invest in our colleagues' growth and reward their efforts.
COV (NYSE)
| Price: | $50.00 |
| Change: | 0.21 |
| Volume: | 192,673 |
Minimum 20 minute delay
-
7/21/2008 9:02:00 AM
Covidien Announces Commitment to Adopt Updated PhRMA Code
MANSFIELD, Mass.--(BUSINESS WIRE)--July 21, 2008--Covidien (NYSE: COV, BSX: COV) today announced that it fully endorses the recent updates to the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals and that its pharmaceutical bus...
-
7/16/2008 9:13:00 AM
Covidien Declares Quarterly Cash Dividend
HAMILTON, Bermuda, Jul 16, 2008 (BUSINESS WIRE) -- Covidien Ltd. (NYSE: COV; BSX: COV) announced today that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on August 11, 2008, to shareholders of record on July 28, 2008.ABOUT CO...
-
7/16/2008 9:01:00 AM
Covidien Launches Optistar(TM) Elite(TM) Contrast Delivery System
New technologically advanced MR power injector helps improve clinical efficiency and reduce potential for certain medication errors
ST. LOUIS--(BUSINESS WIRE)--July 16, 2008--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that ...
-
7/9/2008 8:01:00 AM
Covidien Ltd. to Report Third-Quarter Results on August 5, 2008
HAMILTON, Bermuda--(BUSINESS WIRE)--July 9, 2008--Covidien Ltd. (NYSE: COV, BSX: COV) will report third-quarter results before trading begins on August 5, 2008. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways: